You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DOCOSANOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Docosanol

A generic version of DOCOSANOL was approved as docosanol by P AND L on November 19th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DOCOSANOL?
  • What are the global sales for DOCOSANOL?
  • What is Average Wholesale Price for DOCOSANOL?
Drug patent expirations by year for DOCOSANOL
Drug Prices for DOCOSANOL

See drug prices for DOCOSANOL

Recent Clinical Trials for DOCOSANOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratoire Boreaderme Inc.Phase 2
Ecogene 21Phase 2

See all DOCOSANOL clinical trials

US Patents and Regulatory Information for DOCOSANOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic DOCOSANOL docosanol CREAM;TOPICAL 215839-001 May 3, 2022 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
P And L Development DOCOSANOL docosanol CREAM;TOPICAL 212385-001 Oct 7, 2022 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd DOCOSANOL docosanol CREAM;TOPICAL 217090-001 Mar 1, 2024 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
P And L DOCOSANOL docosanol CREAM;TOPICAL 208754-001 Nov 19, 2018 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro DOCOSANOL docosanol CREAM;TOPICAL 214454-001 Oct 26, 2023 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.